Core Viewpoint - GSK plc is facing a class action securities lawsuit due to alleged securities fraud related to the withdrawal of Zantac from the market, impacting investors between February 5, 2020, and August 14, 2022 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that GSK misrepresented the reasons for removing Zantac from the market, stating it was based on available information and regulatory correspondence, while in reality, GSK was aware of the source of NDMA for nearly 40 years prior to the withdrawal [2]. - GSK assured investors that there was no evidence linking ranitidine therapy to cancer, which the lawsuit argues was materially false or misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until April 7, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Why was Trade Desk Sued for Securities Fraud? Trade Desk is an advertising technology company that offers ad buyers the ability to create and manage data- driven digital advertising campaigns across ad formats and channels. The complaint alleges that during the relevant period, Trade Desk stated it was seeing "massive benefits" surrounding the launch of its next- generation platform, Kokai, and that although it was "already seeing the results of Kokai performance today," it was "just getting started." In tr ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices by KinderCare Learning Companies, Inc. and its officers or directors [1] Group 1: IPO and Financial Performance - KinderCare conducted its initial public offering on October 9, 2024, selling 24 million shares at $24.00 per share [2] - For the fourth quarter of 2024, KinderCare reported an operational loss of $89.3 million, a significant decline from an operational income of $48.7 million in the previous year, attributed to increased equity-based compensation expenses and lower COVID-19 stimulus reimbursements [3] - The full-year guidance provided by KinderCare fell short of consensus estimates [3] Group 2: Stock Price Reaction - Following the announcement of the financial results, KinderCare's stock price dropped by $3.92 per share, or 22.17%, closing at $13.76 per share on March 21, 2025 [4]

Core Viewpoint - BigBear.ai Holdings, Inc. is under investigation for potential securities fraud and unlawful business practices following the disclosure of restated financial statements [1][2] Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. regarding possible securities fraud or other unlawful business practices [1] - The investigation is focused on whether BigBear and certain officers and/or directors have engaged in misconduct [1] Group 2: Financial Disclosure - On March 18, 2025, BigBear disclosed that certain financial statements since fiscal year 2021 should no longer be relied upon and would be restated due to accounting treatment issues related to convertible notes due in 2026 [2] - Following this announcement, BigBear's stock price fell by $0.52 per share, or 14.9%, closing at $2.97 per share on the same day [2]

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fid ...

Core Points - enCore Energy Corp. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements during the class period from March 28, 2024, to March 2, 2025 [3] - The allegations include a lack of effective internal controls over financial reporting, inability to capitalize certain exploratory and development costs under GAAP, and a substantial increase in net losses as a result [3] - The lawsuit claims that the defendants' positive statements about the company's business and prospects were materially misleading and lacked a reasonable basis [3] Shareholder Information - Shareholders who purchased shares during the specified class period are encouraged to register for the class action and can seek lead plaintiff status by the deadline of May 13, 2025 [4] - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4] - There is no cost or obligation for shareholders to participate in this case [4] Legal Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of stock prices [5]

NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Trade Desk, Inc. (NASDAQ: TTD) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Trade Desk, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/the-trade-desk-inc. Investors have until April 21, 2025, to ask the Court to be appoin ...

Core Viewpoint - A lawsuit has been filed against Fluence Energy, Inc. and its senior executives for potential violations of federal securities laws, alleging misrepresentation of the company's competitive position and financial performance [1][2][4]. Company Overview - Fluence Energy specializes in energy storage products and solutions, delivery services, operational and maintenance services, and digital applications for energy storage and power assets [3]. Allegations and Financial Performance - The lawsuit claims that Fluence Energy misrepresented its competitive position, sales pipeline, and backlog of orders, concealing declines in sales and earnings growth through aggressive revenue pull-forwards and selective earnings adjustments [4]. - On February 10, 2025, Fluence Energy reported a net loss of $57 million, or $0.32 per share, with revenues falling 49% year-over-year, and subsequently lowered its revenue guidance for the fiscal year 2025 [6]. Market Reaction - Following the release of negative financial results and a report from Blue Orca Capital revealing legal issues with Siemens Energy, Fluence Energy's stock price declined by 46%, closing at $7.00 per share on February 11, 2025 [5][6].

NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc. Investors have until April 15, 2025, to ask the Court to b ...

Core Viewpoint - A lawsuit has been filed against Atkore Inc. and its senior executives for potential violations of federal securities laws, specifically related to misrepresentations about PVC Pipe pricing and an alleged price-fixing scheme [1][2][5]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until April 23, 2025, to request to lead the case [2]. Group 2: Company Background - Atkore manufactures electrical, safety, and infrastructure products, including PVC Pipe [3]. - During the COVID-19 pandemic, shipping costs increased, impacting foreign PVC Pipe manufacturers' ability to sell profitably in the U.S. [3]. Group 3: Allegations Against Atkore - Atkore allegedly misrepresented the reasons for post-pandemic PVC Pipe price declines, attributing them to "pricing normalization" rather than competitive pressures [4]. - An activist investor report accused Atkore of engaging in an anticompetitive price-fixing scheme that artificially inflated PVC Pipe prices [5]. Group 4: Stock Performance and Impact - Following disappointing earnings and reduced guidance, Atkore's stock price fell nearly 20%, from $79.72 on February 3, 2025, to $64.13 on February 4, 2025 [6]. - The company disclosed a significant portion of the guidance reduction, approximately $75 million or 3/4 of the total, was attributed to its PVC Pipe business [6]. Group 5: Regulatory Scrutiny - On February 14, 2025, Atkore received a grand jury subpoena from the U.S. Department of Justice Antitrust Division regarding the pricing of its PVC products [7].